WVP
FENC icon

Worth Venture Partners’s Fennec Pharmaceuticals FENC Stock Holding History

Worth Venture Partners’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,327
Closed -$115K – 66
2024
Q1 		$115K Sell
10,327
-131,173
-93% -$1.32M 0.76% 35
2023
Q4 		$1.59M Buy
141,500
+48,864
+53% +$405K 0.86% 38
2023
Q3 		$696K Sell
92,636
-616
-0.7% -$5.01K 0.41% 66
2023
Q2 		$823K Buy
93,252
+47,814
+105% +$398K 0.45% 56
2023
Q1 		$378K Buy
+45,438
New +$421K 0.18% 97

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

Worth Venture Partners's FENC Position: Q2 2024 in Review

Worth Venture Partners sold out of Fennec Pharmaceuticals (FENC) in Q2 2024, closing a stake of 10,327 shares — an estimated $115K sold.

Worth Venture Partners first reported a position in FENC in Q1 2023 and held it in 5 quarters. The position peaked at $1.59M in Q4 2023. 64 funds tracked by Wall St. Rank hold FENC as of Q2 2024.

  • Worth Venture Partners reported no remaining Fennec Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Worth Venture Partners sold 10,327 Fennec Pharmaceuticals shares in Q2 2024, an estimated $115K.
  • Worth Venture Partners first reported a position in Fennec Pharmaceuticals in Q1 2023 and held it in 5 quarters.
  • Worth Venture Partners's Fennec Pharmaceuticals position peaked at $1.59M in Q4 2023.
  • 64 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2024.

Based on Worth Venture Partners's 13F filing for Q2 2024, filed 14 Aug 2024.